WHATS NEW - Zacks Investment Research

Zacks Investment Research Page 2 scr.zacks.com WHATS NEW Third Quarter Financial Results ... We discuss what CTRM might be worth in our report below. As of September 30, 2014, the company had $37.6 million in cash and cash equivalents, compared to $7.3 million ... We believe the ultimate patient population for Carticel® in the area of 60,000 ... ................
................